SCHEMBL10132386

SCHEMBL10132386

CCOC(=O)N1CC2CC2(c2ccc(N3CCCCC3)cc2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.47
LMNA P02545 3/20 0.47
GAA P10253 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 6/20 0.43
SMN1; SMN2 Q16637 5/20 0.43
NPC1 O15118 3/20 0.42
RAB9A P51151 3/20 0.42
MAPK1 P28482 2/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HTT P42858 3/20 0.41
TSHR P16473 2/20 0.41
PKM P14618 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10131061 0.90 MAPT (0.46) MAPTLMNAGAAKDM4EALDH1A1
SCHEMBL10132382 0.85 GPR119 (0.46) MAPTLMNAALDH1A1HPGDMGLL
SCHEMBL10132389 0.84 CYP2C19 (0.43) MAPTGAAKDM4EALDH1A1SMN1; SMN2
SCHEMBL2728583 0.84 GPR119 (0.47) MAPTLMNAALDH1A1SMN1; SMN2KMT2A
SCHEMBL10132306 0.82 MAPT (0.54) MAPTLMNAGAAKDM4EALDH1A1
SCHEMBL10132399 0.81 MGLL (0.39) MAPTLMNAGAAKDM4EALDH1A1
SCHEMBL10132333 0.77 KCNH2 (0.47) MAPTGAAKDM4ESMN1; SMN2HTT
SCHEMBL10130902 0.77 KCNH2 (0.47) MAPTGAAKDM4ESMN1; SMN2HTT
SCHEMBL10132331 0.77 KCNH2 (0.47) MAPTGAAKDM4ESMN1; SMN2HTT
SCHEMBL30818047 0.76 OPRM1 (0.50) LMNAKDM4EALDH1A1SMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8906913-B2 Azabicyclohexanes PANACEA BIOTEC LIMITED (IN) 2014-12-09 US disclosed
US-20120165320-A1 NOVEL AZABICYCLOHEXANES PANACEA BIOTEC LTD. (IN) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165320-A1 NOVEL AZABICYCLOHEXANES CYP3A43, UGT1A1, CYP3A4 MAPT 219/4885LMNA 3476/4885GAA 1904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.